Audio

John DeLuca, PhD, Discusses the Assessment and Rehabilitation of Cognitive Impairment in Multiple Sclerosis

Neurology Reviews. 2012 August;20(8):41

 

To read an accompanying article, please click here.

Recommended Reading

MS Use Leads to Free Campath for Leukemia Patients
MDedge Neurology
Will They Still Give Strong to Lance Armstrong's Cancer Charity?
MDedge Neurology
FDA Approves Oral MS Drug Teriflunomide
MDedge Neurology
Ahead of the Journals: DEFINE and CONFIRM Support Oral BG-12’s Efficacy in Multiple Sclerosis
MDedge Neurology
Anthony Reder, MD, Discusses a 21-Year Follow-Up Study of Patients Who Have Multiple Sclerosis
MDedge Neurology
Long-Term Data Indicate Interferon Beta-1b Reduces the Risk of Death for Patients With MS
MDedge Neurology
Interferon Beta May Not Reduce Disability Progression for Patients With MS
MDedge Neurology
Should Patients Continue Natalizumab Treatment After a Positive JCV Test?
MDedge Neurology
Cognitive Rehabilitation Improves Quality of Life in Patients With MS
MDedge Neurology
New and Noteworthy Information—September
MDedge Neurology